Clinical Trial Update: Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating GEN0101 in combination with pembrolizumab for advanced melanoma. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• GEN0101
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Osaka University | Conditions: Advanced Melanoma | Phase 2 | Status: UNKNOWN